Mån 6 dec / År 39 / Nr 4 2021

Taking clinical trials from start to finish

Bringing over two decades of experience, the clinical research organisation IRW Consulting can take projects all the way from the very earliest stages to late stage validated product. IRW manages clinical trials from start to finish and can also act as an integrated part of a client’s research team in-house.

There are various CROs out there, but IRW is most passionate about becoming a preferred partner in the Nordic countries. Providing support from its offices in Sweden, Denmark, Norway and Finland, IRW is concentrating on clients and projects close to home, sharing the aim to strengthen Nordic Life Science companies of all sizes.

A full-service CRO
As a full-service agency, IRW can manage projects from start to end. Clients range from start-up companies to multinational pharmaceutical corporations.
“Our local expertise and contacts mean that we can help our clients to conduct phase I to phase IV studies, including paediatric and non-interventional studies, as well as medical device investigations, according to both international and country-specific guidelines”, says Ola Jeppsson, CEO of IRW Consulting.
“We are able to meet the high demands of our clients and maintain projects efficiently. We have sufficient resources in the form of experienced staff and management teams. We have secured stable business through the years, large parts of the success being due to efficient and strategic planning on our part. We are ready to take on almost any clinical project and bring it through all stages of trials and development”, Ola Jeppsson continues.

Increase in medical device and rare diseases
Lately, IRW has taken a much more prominent role in projects related to medical device investigations as well as rare diseases. Oncology is still widely represented through the project portfolio, as it was the base on which IRW was founded, but there is a significant increase in early stage projects related to the development of medical devices and treatments for rare diseases.
“The year 2020 started off with a healthy increase in new projects for us at IRW. There seems to be a great interest among international companies wanting to conduct clinical studies in the Nordic countries. We are often a preferred partner in these projects, and I personally think that this has a lot to do with our ability to take clinical projects all the way to market”, says Ola Jeppsson.

Expanding staffing solutions
IRW is currently recruiting, with opportunities for clinical research associates and clinical research managers in Denmark, Finland, Norway and Sweden.
“We have started investing more in various staffing solutions where we perform research services in-house in our customers’ facilities. Our expertise ranges from early drug candidate development to late stage testing of medical devices, basically. We can staff almost any laboratory, of any size, almost anywhere in northern Europe. Our strategy is to keep building strong research teams in our own and our clients’ facilities”, Ola Jeppsson concludes.